Posted on 6/13/17
Cellth Systems And University Of Maryland Enter License Agreement
The University of Maryland, Baltimore (UMB) and the University of Maryland, College Park have granted Cellth Systems exclusive licensing rights for the commercial development of cell-tethering . . .
Posted on 6/13/17
RegeneRx Collaborators Receive Notice of Allowance of U.S. Patent for the Treatment of Peripheral Neuropathy
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that a Notice of Allowance has been . . .
Posted on 6/13/17
Maryland Physicians Care announces MyVirtualMPC, Telemedicine Access to ER Physicians, through CirrusMD
Maryland Physicians Care (MPC) members can now skip a trip to urgent care or the ER, instead using instant message or video chat to talk to a local . . .
Posted on 6/13/17
IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine
University of Maryland's Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, "Structure-Based Vaccine Design for Hepatitis C Virus," to . . .
Posted on 6/13/17
Immunomic Therapeutics to Participate in Webcast on Making a Name in Cancer Immunotherapy
ROCKVILLE, Md.--(BUSINESS WIRE)--Sia Anagnostou, Senior Director of Corporate Development at Immunomic Therapeutics, Inc., will participate in a BioPharma Dealmakers webcast, sponsored in part by Immunomic Therapeutics, . . .
Posted on 6/12/17
IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease
BETHESDA, Md., June 12, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) is pleased to announce that it has entered into a definitive license . . .
Posted on 6/8/17
UnitedHealthcare, UMD Quality Care Network Announce Collaboration
University of Maryland Quality Care Network (UMQCN) and UnitedHealthcare are working together in a new accountable care program to improve the quality of health care in . . .
Posted on 6/8/17
These 2 Catalysts Are Behind Novavax, Inc.'s 12% Rise in May
What happenedShares of Novavax (NASDAQ:NVAX), a clinical-stage biotech focused on the development of recombinant nanoparticle vaccines and adjuvants for the treatment of respiratory syncytial virus, surged . . .
Posted on 6/8/17
Rexahn Announces $10 Million Registered Direct Offering
ROCKVILLE, Md., June 07, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) today announced it has entered into definitive agreements with institutional investors to purchase . . .
Posted on 6/7/17
Capital Digestive Care Opens New Office in Prince George’s County
Capital Digestive Care has announced the opening of a new location to serve residents of Prince George’s County. It is located on 12150 Annapolis Road in Glenn . . .
Posted on 6/7/17
Reza Abrishamchian Joins MedStar Heart & Vascular Institute at MedStar Union Memorial Hospital
Cardiothoracic surgeon Reza Abrishamchian, MD, MPH, FACS, has joined MedStar Heart & Vascular Institute
Posted on 6/6/17
CSSi to Showcase Latest Innovations at 53rd Drug Information Association Annual Meeting
Unique Patient Recruitment Solutions to Help Solve the Industry’s Biggest ChallengesCSSi, the global leader in patient recruitment, enrollment, and retention solutions for the clinical research industry, . . .
Posted on 6/6/17
This Startup Is Developing A Vaccine For Staph Infections
Drug companies poured lots of resources into seeking a vaccine for staph infections, but have yet to succeed.
Posted on 6/6/17
National Kidney Foundation of Maryland Holding Orioles Fundraiser Night, June 21
LUTHERVILLE, Md. – The National Kidney Foundation of Maryland invites you to take your friends and family out to the ballpark for a night of entertainment, . . .
Posted on 6/6/17
CEL-SCI Submits FDA Response for Its Phase 3 Head and Neck Cancer Trial
CEL-SCI Corporation (NYSE MKT: CVM) today announced that it has responded to the U.S. Food and Drug Administration's (FDA) most recent communication from May 2017 about the clinical . . .
Posted on 6/5/17
Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology
Personal Genome Diagnostics Inc. (PGDx), a pioneer in cancer genomic testing, today highlighted its patent-pending microsatellite instability (MSI) testing technology following the U.S. Food and Drug . . .
Posted on 6/5/17
Greg Boucher Joins The Braff Group as Managing Director for Health Care Information Technology
?Greg has extensive experience working with middle market businesses in M&A advisory, strategic planning, and
Posted on 6/15/17
Luis Branco, Zalgen Labs: Uncovering and Treating ‘Neglected’ Diseases
By now you’ve probably heard about the Ebola
Posted on 6/4/17
Portable Alternative Crib Startup Wins 25k
A mother looking to prevent cases of sudden infant death syndrome in Maryland has won $25,000 to help fund her "baby box" startup concept. As a . . .
Posted on 6/2/17
Ciena: Heading To $30
Shares of fiber optic specialist Ciena Corporation (NASDAQ:CIEN) are surging more than 9% in Thursday's pre-market session, reaching a session high of $25.74 after the optical . . .
Posted on 6/1/17
Kickboxing Gym 9Round Selects Belair Beltway Plaza For Second Franchise Location In Greater Baltimore Area
Local franchise holders Ken and Julie Jacobs parlayed employee severance package from Air Products to pursue expansion of nine station, thirty-minute fitness concept Ken and Julie . . .
Posted on 6/1/17
Ciena Beats By $0.16, Beats On Revenue
Ciena® Corporation (NYSE: CIEN), a network strategy and technology company, today announced unaudited financial results for its fiscal second quarter ended April 30, 2017.For the fiscal . . .
Posted on 6/1/17
Aziyo Biologics Acquires CorMatrix Assets
SILVER SPRING, Md.--(BUSINESS WIRE)--Aziyo Biologics, Inc. a fully integrated regenerative medicine company, today announced it has completed an asset purchase agreement with CorMatrix® Cardiovascular, Inc. for . . .
Posted on 5/31/17
FDA Approves First Generic Strattera for the Treatment of ADHD
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.Apotex Inc., . . .
Posted on 5/31/17
GlycoMimetics Closes Public Offering
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the closing of its underwritten public offering of 8,050,000 shares of its common stock at a public offering . . .
Baltimore
